Literature DB >> 26824656

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton.

Hai Hu1, Ashish Juvekar1, Costas A Lyssiotis2, Evan C Lien3, John G Albeck4, Doogie Oh5, Gopal Varma6, Yin Pun Hung7, Soumya Ullas8, Josh Lauring9, Pankaj Seth10, Mark R Lundquist2, Dean R Tolan11, Aaron K Grant6, Daniel J Needleman5, John M Asara12, Lewis C Cantley2, Gerburg M Wulf13.   

Abstract

The phosphoinositide 3-kinase (PI3K) pathway regulates multiple steps in glucose metabolism and also cytoskeletal functions, such as cell movement and attachment. Here, we show that PI3K directly coordinates glycolysis with cytoskeletal dynamics in an AKT-independent manner. Growth factors or insulin stimulate the PI3K-dependent activation of Rac, leading to disruption of the actin cytoskeleton, release of filamentous actin-bound aldolase A, and an increase in aldolase activity. Consistently, PI3K inhibitors, but not AKT, SGK, or mTOR inhibitors, cause a significant decrease in glycolysis at the step catalyzed by aldolase, while activating PIK3CA mutations have the opposite effect. These results point toward a master regulatory function of PI3K that integrates an epithelial cell's metabolism and its form, shape, and function, coordinating glycolysis with the energy-intensive dynamics of actin remodeling.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26824656      PMCID: PMC4898774          DOI: 10.1016/j.cell.2015.12.042

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  36 in total

Review 1.  Cellular concentrations of enzymes and their substrates.

Authors:  K R Albe; M H Butler; B E Wright
Journal:  J Theor Biol       Date:  1990-03-22       Impact factor: 2.691

2.  Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation.

Authors:  Pascal Furet; Vito Guagnano; Robin A Fairhurst; Patricia Imbach-Weese; Ian Bruce; Mark Knapp; Christine Fritsch; Francesca Blasco; Joachim Blanz; Reiner Aichholz; Jacques Hamon; Doriano Fabbro; Giorgio Caravatti
Journal:  Bioorg Med Chem Lett       Date:  2013-05-14       Impact factor: 2.823

3.  The molecular nature of the F-actin binding activity of aldolase revealed with site-directed mutants.

Authors:  J Wang; A J Morris; D R Tolan; L Pagliaro
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

4.  Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor.

Authors:  Yin Pun Hung; John G Albeck; Mathew Tantama; Gary Yellen
Journal:  Cell Metab       Date:  2011-10-05       Impact factor: 27.287

5.  PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.

Authors:  Chia-Yen C Wu; Eileen S Carpenter; Kenneth K Takeuchi; Christopher J Halbrook; Louise V Peverley; Harold Bien; Jason C Hall; Kathleen E DelGiorno; Debjani Pal; Yan Song; Chanjuan Shi; Richard Z Lin; Howard C Crawford
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

6.  Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.

Authors:  Saskia M Brachmann; Claudine M Yballe; Metello Innocenti; Jonathan A Deane; David A Fruman; Sheila M Thomas; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Aldolase isozymes in cancer.

Authors:  F Schapira
Journal:  Eur J Cancer       Date:  1966-06       Impact factor: 9.162

8.  RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase.

Authors:  T Joneson; M McDonough; D Bar-Sagi; L Van Aelst
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

9.  Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Authors:  Ingrid A Mayer; Vandana G Abramson; Steven J Isakoff; Andres Forero; Justin M Balko; María Gabriela Kuba; Melinda E Sanders; Jeffrey T Yap; Annick D Van den Abbeele; Yisheng Li; Lewis C Cantley; Eric Winer; Carlos L Arteaga
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

10.  Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.

Authors:  J Lauring; D P Cosgrove; S Fontana; J P Gustin; H Konishi; A M Abukhdeir; J P Garay; M Mohseni; G M Wang; M J Higgins; D Gorkin; M Reis; B Vogelstein; K Polyak; M Cowherd; P J Buckhaults; B H Park
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more
  140 in total

1.  Dysregulated actin dynamics in activated PI3Kδ syndrome.

Authors:  Jacqueline G Wallace; Pedro Zambrano-Rodas; Wilmer Córdova-Calderón; Santiago Estrada-Turriate; Daniel Mendoza-Quispe; Yesenia Limache Ontiveros; Raif S Geha; Janet Chou; Craig D Platt
Journal:  Clin Immunol       Date:  2019-11-21       Impact factor: 3.969

Review 2.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 3.  Cancer metabolism gets physical.

Authors:  Peter DelNero; Benjamin D Hopkins; Lewis C Cantley; Claudia Fischbach
Journal:  Sci Transl Med       Date:  2018-05-23       Impact factor: 17.956

Review 4.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 5.  Exercise-stimulated glucose uptake - regulation and implications for glycaemic control.

Authors:  Lykke Sylow; Maximilian Kleinert; Erik A Richter; Thomas E Jensen
Journal:  Nat Rev Endocrinol       Date:  2016-10-14       Impact factor: 43.330

6.  Cell forces meet cell metabolism.

Authors:  Tadamoto Isogai; Jin Suk Park; Gaudenz Danuser
Journal:  Nat Cell Biol       Date:  2017-05-31       Impact factor: 28.824

7.  Size-Dependent Cortical Compaction Induces Metabolic Adaptation in Mesenchymal Stem Cell Aggregates.

Authors:  Brent M Bijonowski; Susan I Daraiseh; Xuegang Yuan; Teng Ma
Journal:  Tissue Eng Part A       Date:  2019-04       Impact factor: 3.845

8.  Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion.

Authors:  Ashish Juvekar; Hai Hu; Sina Yadegarynia; Costas A Lyssiotis; Soumya Ullas; Evan C Lien; Gary Bellinger; Jaekyoung Son; Rosanna C Hok; Pankaj Seth; Michele B Daly; Baek Kim; Ralph Scully; John M Asara; Lewis C Cantley; Gerburg M Wulf
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

Review 9.  PI3K signaling in cancer: beyond AKT.

Authors:  Evan C Lien; Christian C Dibble; Alex Toker
Journal:  Curr Opin Cell Biol       Date:  2017-03-24       Impact factor: 8.382

Review 10.  Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.

Authors:  Yongting Lai; Hairong Huang; Mubalake Abudoureyimu; Xinrong Lin; Chuan Tian; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.